Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Capricorn Pharma is a specialty pharmaceutical company and contract development and manufacturing organization (CDMO) headquartered in Frederick, Maryland. Established in 1994, the company specializes in the development of advanced drug delivery systems, particularly for oral and topical administration. Their core competencies include controlled-release technologies, taste-masking for pediatric and geriatric applications, and solubility enhancement for poorly soluble compounds. Capricorn operates a GMP-compliant facility capable of handling projects from initial formulation and analytical testing through to commercial-scale production. The company primarily focuses on the 505(b)(2) regulatory pathway and the development of value-added generic products. By leveraging its proprietary delivery platforms, Capricorn aims to improve therapeutic outcomes and patient compliance across various therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Capricorn Pharma.